Quest Diagnostics (NYSE:DGX) reported double-digit revenue growth and raised its full-year 2026 outlook after what executives ...

July 23 (Reuters) - Quest Diagnostics on Thursday raised its full-year profit forecast, after demand for routine diagnostic testing helped the company beat second-quarter estimates. Shares of the ​New ...

Nearly half of U.S. employers have dropped marijuana testing for some job applicants, even as workplace drug tests show ...

Quest Diagnostics Incorporated DGX stock surged Thursday after the diagnostic testing company reported second-quarter results ...

Today (the 23rd) at CEDEC 2026, Capcom presented a session on the industry-trending topic of AI in game development, using ...

Quest Diagnostics crushed Q2 earnings with a 10.5% EPS beat fueled by a 13.1% surge in testing volume, lifting the company's full-year guidance on broad momentum in Alzheimer's blood tests and ...

Healthcare diagnostics company Quest Diagnostics (NYSE:DGX) beat Wall Street’s revenue expectations in Q2 CY2026, with sales ...

The clearance gives New York clinicians access to the Haystack MRD assay, which detects residual or recurring solid tumour disease.

Neither Old Trafford nor Headingley will host a men's Ashes Test between England and Australia next summer.

Second quarter revenues of $3.04 billion, up 10.2% from 2025, with 10.0% organic revenue growth Second quarter reported diluted earnings per share ("EPS") of $2.84 ...

In the never-ending quest to understand ourselves better, or at least have just one more distraction from whatever it is we should be doing, here comes the animal personality test. And the craziest ...

More US workers are testing positive for cannabis and it has employers worried they are high on the job - Major corporations ...